Millrace Asset Group’s Transmedics TMDX Stock Holding History

Millrace Asset Group’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$724K	Sell	4,611 -57	-1%	-$8.78K	0.74%	57
2024 Q2	$703K	Sell	4,668 -17,760	-79%	-$2.13M	0.68%	65
2024 Q1	$1.66M	Buy	22,428 +14,305	+176%	+$1.18M	1.67%	23
2023 Q4	$641K	Sell	8,123 -3,759	-32%	-$227K	0.63%	60
2023 Q3	$651K	Sell	11,882 -1,958	-14%	-$141K	0.8%	52
2023 Q2	$1.16M	Buy	13,840 +531	+4%	+$40.6K	1.22%	37
2023 Q1	$1.01M	Sell	13,309 -4,631	-26%	-$320K	1.18%	40
2022 Q4	$1.11M	Sell	17,940 -2,378	-12%	-$126K	1.26%	38
2022 Q3	$848K	Sell	20,318 -6,428	-24%	-$280K	1.07%	38
2022 Q2	$841K	Sell	26,746 -46,511	-63%	-$1.24M	0.79%	50
2022 Q1	$1.97M	Sell	73,257 -10,466	-13%	-$188K	1.43%	33
2021 Q4	$1.6M	Buy	+83,723	New	+$2.1M	0.94%	49

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millrace Asset Group's TMDX Position: Q3 2024 in Review

Millrace Asset Group reduced its Transmedics (TMDX) stake by 1.2% in Q3 2024, selling an estimated $8.78K and leaving 4,611 shares worth $724K. The position accounts for 0.74% of the portfolio, ranked #57.

Millrace Asset Group first reported a position in TMDX in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.97M in Q1 2022. 373 funds tracked by Wall St. Rank hold TMDX as of Q3 2024.

Millrace Asset Group held 4,611 shares of Transmedics worth $724K as of Q3 2024.
Millrace Asset Group sold 57 Transmedics shares in Q3 2024, an estimated $8.78K.
Transmedics made up 0.74% of Millrace Asset Group's portfolio in Q3 2024, its #57 holding.
Millrace Asset Group first reported a position in Transmedics in Q4 2021 and has held it in 12 quarters since.
Millrace Asset Group's Transmedics position peaked at $1.97M in Q1 2022.
373 funds tracked by Wall St. Rank held Transmedics as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.